Mebendazole

Q: What is the mechanism of the antiparasitic action of mebendazole at the cellular level?

Inhibitors of microtubule synthesis — Mebendazole disrupts tubulin polymerization, which blocks the transport of nutrients in helminth cells.

Q: Which specific nosologies (types of helminthiases) are indications for mebendazole prescription?

Enterobiasis — Intestinal nematodiasis caused by pinworms (Enterobius vermicularis).Ascariasis — Intestinal helminthic nematodiasis included in the spectrum of the drug's antihelminthic activity.

*Mebendazolum*

For medical students2 min readUpdated 2026-10-10

Mebendazole (Mebendazolum) is an anthelmintic medication belonging to the class of antinematodal agents. In clinical practice, it is used to treat all types of intestinal nematode infections, demonstrating high efficacy even in mixed helminthic infestations.

Pharmacological classAntinematodal agent

Spectrum of activityAll intestinal nematodes, including polyparasitism

Absorption characteristicsOver 90% is not absorbed into the systemic circulation

Age restrictionsStrictly contraindicated in children under 2 years of age

Spectrum of Antiparasitic Activity

The primary target for this drug is the causative agents of intestinal nematodes. The drug features a broad spectrum of activity against roundworms residing in the human digestive system.

Of particular value in medical practice is the drug's ability to affect mixed infestations. In situations where a patient is infected with multiple species of parasites simultaneously (a condition defined in clinical parasitology as polyparasitism), prescribing this agent avoids the need for multiple narrowly targeted drugs, ensuring comprehensive clearance of various nematodes from the intestines.

Pharmacokinetic Features

The pharmacokinetic profile of the drug has distinct specificities that directly determine its clinical use and administration guidelines for patients.

Absorption and excretion: The overwhelming majority of the administered dose (over 90%) is not absorbed in the gastrointestinal tract at all. The active substance remains directly within the intestinal lumen, where it exerts its antihelminthic effect on parasites. Subsequently, the drug is excreted from the body in feces in an entirely unchanged form.
Food interaction: It is crucial to consider the patient's diet during therapy. Consumption of fatty foods radically alters pharmacokinetics: fats promote a sharp increase in the absorption of the active substance. This means that instead of acting locally in the gut, the drug begins to penetrate the systemic circulation more actively, which is an undesirable effect.

Safety Profile and Side Effects

Despite the fact that the bulk of the drug is normally not absorbed, a range of adverse reactions may develop during therapy. They can be divided into several clinical groups:

General systemic reactions: Patients may experience unexplained fever, episodes of vomiting, and pronounced headaches.
Allergic and dermatological manifestations: Skin reactions in the form of pruritic rashes are possible. Cases of hair loss (alopecia) have been reported with high doses of the drug.
Hematological abnormalities: Regarding the hematopoietic system, the drug can cause specific suppression of the leukocyte lineage, manifesting as neutropenia (a pathological decrease in the number of neutrophils in peripheral blood).

Strict Contraindications

Prescribing therapy requires careful history taking, as there are several conditions in which the use of this antinematodal agent is strictly prohibited:

Intestinal ulcerations: This is one of the most critical contraindications. When the integrity of the gastrointestinal mucosa is compromised, there is a serious risk of uncontrolled enhancement of drug absorption into the systemic circulation, vastly increasing the likelihood of toxic effects.
Liver pathologies: Any impairment of liver function makes the safe use of the medication impossible.
Blood disorders: A diagnosed anemia in the patient is a direct limitation to initiating therapy.
Special periods of life: The drug is strictly contraindicated during pregnancy and breastfeeding (lactation).
Pediatric practice: In childhood, use is strictly limited — the medication is not prescribed to infants under two years of age.

Mnemonic

To quickly remember the contraindications, use the mnemonic P-U-B-S-A (or equivalent clinical categories): Pathology of the liver, Ulcers of the intestine, Blood toxicity (anemia), Small children (under 2 years), Aexpectancy/Pregnancy and lactation.

Frequently asked questions

What is the mechanism of the antiparasitic action of mebendazole at the cellular level?

Inhibitors of microtubule synthesis — Mebendazole disrupts tubulin polymerization, which blocks the transport of nutrients in helminth cells.

Which specific nosologies (types of helminthiases) are indications for mebendazole prescription?

Enterobiasis — Intestinal nematodiasis caused by pinworms (Enterobius vermicularis).
Ascariasis — Intestinal helminthic nematodiasis included in the spectrum of the drug's antihelminthic activity.

Does diet affect the efficacy and safety of treatment?

Yes, diet plays a key role. Consuming fatty foods during the course of treatment significantly enhances the absorption of the active substance from the gastrointestinal lumen. This is undesirable because it increases the risk of systemic side effects.

Why is the drug contraindicated in peptic ulcer disease of the intestine?

In ulcerative lesions, the barrier function of the intestinal mucosa is impaired. This creates a high risk of uncontrolled increased absorption of the drug into the systemic circulation, whereas normally more than 90% of the dose should remain within the lumen of the digestive tract.

What blood abnormalities serve as a contraindication to administration?

A strict contraindication to prescription is the presence of anemia in the patient. Furthermore, during therapy itself, the physician must account for the risk of developing another hematological abnormality — neutropenia.

Is the drug effective if the patient is infected with multiple species of roundworms simultaneously?

Yes, the drug has a broad spectrum of activity and is successfully used in mixed infestations (polyparasitism), effectively eradicating various causative agents of intestinal nematodes.

Go deeper

Pathogenesis of alopecia development during the use of high doses of antinematodal agents
Mechanisms of hepatic impairment secondary to systemic absorption of anthelmintic drugs
Management of intestinal polyparasitism in pediatric practice for children over two years old
Influence of dietary lipids on the pharmacokinetics of drugs with initially low bioavailability
Hematotoxicity: mechanisms of neutropenia development during antiparasitic therapy